PROGRESSIVE FIBROSING INTERSTICIAL LUNG DISEASE OF AUTOIMMUNE ORIGIN AND ANTIFIBROTIC MEDICATION: SOCIODEMOGRAPHIC, CLINICAL AND THERAPEUTIC CHARACTERISTICS OF THE NEREA COHORT | Publicación